This article needs additional citations for verification. Please help improve this articlebyadding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Yuhan" – news · newspapers · books · scholar · JSTOR (March 2017) (Learn how and when to remove this message) |
Native name | 주식회사 유한양행 |
---|---|
Company type | Public |
KRX: 000100 | |
Industry | Pharmaceutical |
Founded | 1926; 98 years ago (1926) |
Founder | Ilhan New |
Headquarters | , |
Key people | Cho Wook-je (Chairman & CEO) |
Website | eng |
Footnotes / references [1] |
Yuhan | |
Hangul | 유한양행 |
---|---|
Hanja | |
Revised Romanization | Yuhan Yanghaeng |
McCune–Reischauer | Yuhan Yanghaeng |
Yuhan Corporation (Korean: 주식회사 유한양행; Hanja: 株式會社 柳韓洋行; RR: Jusik Hoesa Yuhan Yanghaeng) is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962.[1][2] Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical.[3]
International |
|
---|---|
National |
|